Literature DB >> 17893225

Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging.

Y Ge1, J H Jensen, H Lu, J A Helpern, L Miles, M Inglese, J S Babb, J Herbert, R I Grossman.   

Abstract

BACKGROUND AND
PURPOSE: Deposition of iron has been recognized recently as an important factor of pathophysiologic change including neurodegenerative processes in multiple sclerosis (MS). We propose that there is an excess accumulation of iron in the deep gray matter in patients with MS that can be measured with a newly developed quantitative MR technique--magnetic field correlation (MFC) imaging.
MATERIALS AND METHODS: With a 3T MR system, we studied 17 patients with relapsing-remitting MS and 14 age-matched healthy control subjects. We acquired MFC imaging using an asymmetric single-shot echo-planar imaging sequence. Regions of interest were selected in both deep gray matter and white matter regions, and the mean MFC values were compared between patients and controls. We also correlated the MFC data with lesion load and neuropsychologic tests in the patients.
RESULTS: MFC measured in the deep gray matter in patients with MS was significantly higher than that in the healthy controls (P < or = .03), with an average increase of 24% in the globus pallidus, 39.5% in the putamen, and 30.6% in the thalamus. The increased iron deposition measured with MFC in the deep gray matter in the patients correlated positively with the total number of MS lesions (thalamus: r = 0.61, P = .01; globus pallidus: r = 0.52, P = .02). A moderate but significant correlation between the MFC value in the deep gray matter and the neuropsychologic tests was also found.
CONCLUSION: Quantitative measurements of iron content with MFC demonstrate increased accumulation of iron in the deep gray matter in patients with MS, which may be associated with the disrupted iron outflow pathway by lesions. Such abnormal accumulation of iron may contribute to neuropsychologic impairment and have implications for neurodegenerative processes in MS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17893225      PMCID: PMC8134218          DOI: 10.3174/ajnr.A0646

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  35 in total

1.  Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing-remitting MS.

Authors:  M Inglese; S Liu; J S Babb; L J Mannon; R I Grossman; O Gonen
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

2.  Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity.

Authors:  Robert A Bermel; Srinivas R Puli; Richard A Rudick; Bianca Weinstock-Guttman; Elizabeth Fisher; Frederick E Munschauer; Rohit Bakshi
Journal:  Arch Neurol       Date:  2005-09

3.  Magnetic field correlation imaging.

Authors:  Jens H Jensen; Ramesh Chandra; Anita Ramani; Hanzhang Lu; Glyn Johnson; Sang-Pil Lee; Kyle Kaczynski; Joseph A Helpern
Journal:  Magn Reson Med       Date:  2006-06       Impact factor: 4.668

4.  Magnetic resonance imaging in multiple sclerosis: decreased signal in thalamus and putamen.

Authors:  B P Drayer; P Burger; B Hurwitz; D Dawson; J Cain; J Leong; R Herfkens; G A Johnson
Journal:  Ann Neurol       Date:  1987-10       Impact factor: 10.422

Review 5.  Multiple sclerosis: a white matter disease with associated gray matter damage.

Authors:  M Filippi
Journal:  J Neurol Sci       Date:  2001-03-15       Impact factor: 3.181

6.  Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients.

Authors:  R Bakshi; J Dmochowski; Z A Shaikh; L Jacobs
Journal:  J Neurol Sci       Date:  2001-03-15       Impact factor: 3.181

7.  The measurement of R2, R2* and R2' in HIV-infected patients using the prime sequence as a measure of brain iron deposition.

Authors:  K A Miszkiel; M N Paley; I D Wilkinson; M A Hall-Craggs; R Ordidge; B E Kendall; R F Miller; M J Harrison
Journal:  Magn Reson Imaging       Date:  1997       Impact factor: 2.546

Review 8.  Quantitative MRI assessment of Alzheimer's disease.

Authors:  Joseph A Helpern; Jens Jensen; Sang-Pil Lee; Maria F Falangola
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content?

Authors:  B Drayer; P Burger; B Hurwitz; D Dawson; J Cain
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

10.  Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children.

Authors:  R B Dietrich; W G Bradley
Journal:  Radiology       Date:  1988-07       Impact factor: 11.105

View more
  55 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Automated brain tissue segmentation based on fractional signal mapping from inversion recovery Look-Locker acquisition.

Authors:  Wanyong Shin; Xiujuan Geng; Hong Gu; Wang Zhan; Qihong Zou; Yihong Yang
Journal:  Neuroimage       Date:  2010-05-07       Impact factor: 6.556

Review 3.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

4.  Toward a better understanding of brain lesions during metachromatic leukodystrophy evolution.

Authors:  A Martin; C Sevin; C Lazarus; C Bellesme; P Aubourg; C Adamsbaum
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-26       Impact factor: 3.825

5.  Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women.

Authors:  Y Li; K L Munger; S Batool-Anwar; K De Vito; A Ascherio; X Gao
Journal:  Neurology       Date:  2012-04-25       Impact factor: 9.910

6.  Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation.

Authors:  David L Schonberg; Dana M McTigue
Journal:  Exp Neurol       Date:  2009-04-15       Impact factor: 5.330

7.  Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders.

Authors:  Niels Bergsland; Eleonora Tavazzi; Ferdinand Schweser; Dejan Jakimovski; Jesper Hagemeier; Michael G Dwyer; Robert Zivadinov
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

8.  Brain iron quantification in mild traumatic brain injury: a magnetic field correlation study.

Authors:  E Raz; J H Jensen; Y Ge; J S Babb; L Miles; J Reaume; R I Grossman; M Inglese
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-01       Impact factor: 3.825

Review 9.  MRI in multiple sclerosis: current status and future prospects.

Authors:  Rohit Bakshi; Alan J Thompson; Maria A Rocca; Daniel Pelletier; Vincent Dousset; Frederik Barkhof; Matilde Inglese; Charles R G Guttmann; Mark A Horsfield; Massimo Filippi
Journal:  Lancet Neurol       Date:  2008-07       Impact factor: 44.182

10.  Multimodal MR imaging of brain iron in attention deficit hyperactivity disorder: a noninvasive biomarker that responds to psychostimulant treatment?

Authors:  Vitria Adisetiyo; Jens H Jensen; Ali Tabesh; Rachael L Deardorff; Els Fieremans; Adriana Di Martino; Kevin M Gray; Francisco X Castellanos; Joseph A Helpern
Journal:  Radiology       Date:  2014-06-17       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.